SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-305076
Filing Date
2022-12-15
Accepted
2022-12-14 21:49:51
Documents
12
Period of Report
2022-12-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d429598d8k.htm   iXBRL 8-K 311959
  Complete submission text file 0001193125-22-305076.txt   463387

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20221214.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20221214_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20221214_pre.xml EX-101.PRE 12157
6 EXTRACTED XBRL INSTANCE DOCUMENT d429598d8k_htm.xml XML 3586
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 221463539
SIC: 2834 Pharmaceutical Preparations